CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Resapp Health Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Resapp Health Ltd
Level 12, 100 Creek St
Phone: +61 737240035p:+61 737240035 BRISBANE, QLD  4000  Australia Fax: +61 892188875f:+61 892188875
This company was Merged or Acquired on 9/27/2022.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
ResApp Health Limited is an Australia-based digital health company engaged in developing smartphone applications for the diagnosis and management of respiratory disease. The Company provides point of care diagnostic solutions for telehealth that are integrated into existing platforms. The Company is focused on developing apps to provide instant clinical diagnostic tests and management tools directly to consumers and healthcare providers. The Company’s machine learning algorithms use sound to diagnose and measure the severity of respiratory conditions without the need for additional accessories or hardware. Its products include ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department and primary care settings; and SleepCheck, a smartphone application which allows consumers to self-assess their risk of sleep apnoea. Its obstructive sleep aponia screening test uses overnight breathing and snoring sounds recorded on a smartphone.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20226/30/2022Yes----

Industries
SIC Code Description
7372 Prepackaged software

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board RogerAston 7/2/2015 7/2/2015
Chief Executive Officer, Managing Director, Executive Director TonyKeating 7/2/2015 7/2/2015
Executive Director - Corporate Affairs BrianLeedman 5/18/2021 2/22/2016
3 additional Officers and Directors records available in full report.

Business Names
Business Name
lNarhex Life Sciences Limited
Narhex Life Sciences Limited
RAP
RAPHF
ResApp Diagnostics Pty Ltd
ResApp Health (UK) Limited

General Information
Number of Employees: 3 (As of 6/30/2005)
Outstanding Shares: 859,697,077 (As of 6/30/2022)
Shareholders: 6,512
Stock Exchange: ASX
Fax Number: +61 892188875


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 1, 2024